MoneyWorks4Me

Adline Chem Lab - Quaterly Results

21 May 2025 Evaluate
The revenue slipped marginally during the March 2025 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2025 of Rs. 2.10 millions grew from Rs.-0.88 millions Operating profit Margin for the quarter ended March 2025 improved to 1.91% as compared to -0.64% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 2.49 0.00 0.00 2.49 0.00 0.00 2.49 0.00 0.00
PBIDT 1.91 -0.64 -398.44 -0.74 -1.79 -58.66 -0.74 -1.79 -58.66
Interest 0.29 0.32 -9.38 1.31 1.24 5.65 1.31 1.24 5.65
PBDT 1.62 -0.96 -268.75 -2.05 -3.03 -32.34 -2.05 -3.03 -32.34
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 1.62 -0.96 -268.75 -2.05 -3.03 -32.34 -2.05 -3.03 -32.34
TAX -0.48 -0.08 500.00 -0.74 -0.31 138.71 -0.74 -0.31 138.71
Deferred Tax 0.54 -0.09 -700.00 0.28 -0.32 -187.50 0.28 -0.32 -187.50
PAT 2.10 -0.88 -338.64 -1.31 -2.72 -51.84 -1.31 -2.72 -51.84
Equity 58.50 58.50 0.00 58.50 58.50 0.00 58.50 58.50 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..